EurekAlert! In the Spotlight - Artificial Intelligence

Welcome to In the Spotlight, where each month we shine a light on something exciting, timely, or simply fascinating from the world of science.

This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.

Latest News Releases

Updates every hour. Last Updated: 3-Nov-2026 09:17 ET (3-Nov-2026 14:17 GMT/UTC)

31-Aug-2026

Artificial intelligence could help unlock smarter biochar strategies for acidic soils

Biochar Editorial Office, Shenyang Agricultural University
Peer-Reviewed Publication

Soil acidification threatens agricultural productivity across large areas of the world, but predicting how well biochar can restore acidic soils remains difficult. A new review suggests that artificial intelligence could help scientists move from trial-and-error applications toward more precise, mechanism-guided biochar management, provided that researchers improve the quality and biological relevance of the data used to train AI models.

Journal: Biochar

31-Aug-2026

NEW HORIZON PRESS LIMITED strengthens global research connections at ACS Fall 2026

Biochar Editorial Office, Shenyang Agricultural University
Meeting Announcement

CHICAGO, August 27, 2026. NEW HORIZON PRESS LIMITED participated as an exhibitor at ACS Fall 2026, held from August 23 to 27 in Chicago, connecting with researchers, scholars, and students from around the world and introducing its academic journals and publishing initiatives to the international scientific community.

31-Aug-2026

Marshall University research identifies lasting brain changes associated with adolescent binge alcohol exposure

Marshall University Joan C. Edwards School of Medicine
Peer-Reviewed Publication

New research from the Marshall University Joan C. Edwards School of Medicine provides insight into how binge alcohol exposure during adolescence may cause lasting changes in brain function that persist into adulthood, potentially identifying a new target for future treatment approaches.

The study, published August 15 in Molecular Psychiatry, found that intermittent ethanol exposure during adolescence disrupted communication between astrocytes—supportive brain cells increasingly recognized for their role in neural signaling—and synapses in the hippocampus, a region of the brain important for learning and memory.

Journal: Molecular Psychiatry

31-Aug-2026

Study explores why some AI ads fail while others succeed

University of Mississippi
Peer-Reviewed Publication

When should marketers use artificial intelligence? Researchers recently studied cases where AI-powered ads succeeded and failed to give marketers insights into how to use the emerging technology.

Journal: Journal of Interactive Advertising

31-Aug-2026

Every organ ages on its own schedule—and the schedules are in sync

Sanford Burnham Prebys
Peer-Reviewed Publication

A new study of aging in our organs found that each organ ages on its own schedule. Arteries remodel fastest from age 30-39 while reproductive organs do so at menopause.

Most of our body ages in two waves, and those who experience aging more rapidly in one organ also have accelerated aging in partner organs. The researchers built a map from analyzing 25,000 organ images that points to hormonal signaling as a possible conductor of this symphony of aging throughout the body.

Journal: Nature Aging

31-Aug-2026

New tools predict which tumors will respond to treatment by comparing their internal “floor plans”

University of Chicago
Peer-Reviewed Publication

Borrowing from the study of complex systems like flocks of birds and microbial communities, UChicago researchers built AI tools that compare the spatial organization of tumors — a step toward personalized cancer treatment.

Journal: Cell Reports Medicine

31-Aug-2026

Beyond trial and error: A more precise approach to psychiatry

Virginia Tech
Meeting Announcement

Scientists, clinicians, federal researchers and pharmaceutical leaders are gathering at Virginia Tech to consider whether psychiatry can move beyond trial-and-error treatment. The inaugural Precision Psychiatry Symposium will examine new schizophrenia medications, emerging biomarkers, artificial intelligence and advances in neuroscience that could help match patients with effective treatments sooner, while highlighting a research and clinical partnership in Roanoke, Virginia, in September.

Funder: Bristol-Myers Squibb, Ovid Therapeutics, Fralin Biomedical Research Institute